Olympus Takes Stake in Dutch Startup PamGene; Cos to Jointly Develop Microarrays

Mar 14, 2001

NEW YORK, March 14 - PamGene, a Dutch microarray startup, and Olympus Optical have agreed to jointly develop a platform for manufacturing and analyzing DNA microarrays, the companies said Wednesday.

As part of the alliance, Olympus has made a "significant" equity investment in PamGene, based in Den Bosch, the Netherlands. Exact financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu